Wiedenmann, Bertram

Publishing since 1983 (Dinosaur)

Has published 240 publications in 28 years

Number of publications published per year by Wiedenmann, Bertram. (Source : PubMed)

Distribution of publications types for Wiedenmann, Bertram. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.  Am. J. Surg. Pathol.  2010;34;3  
•  Küster K, Grötzinger C, Koschel A, Fischer A, Wiedenmann B, Anders M. Sodium butyrate increases expression of the coxsackie and adenovirus receptor in colon cancer cells.  Cancer Invest.  2010;28;3  
•  Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.  J. Gastroenterol.  2010;45;2  
•  Kaczmarek P, Singh V, Cashen DE, Yang L, Berk S, Pasternak A, Xiong Y, Shen DM, Hutchins SM, Chapman K, Wiedenmann B, Schaeffer JM, Strowski MZ. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.  Neurogastroenterol. Motil.  2010;22;2  
•  Küster K, Koschel A, Rohwer N, Fischer A, Wiedenmann B, Anders M. Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1alpha.  Cancer Gene Ther.  2010;17;2  
•  Detjen KM, Rieke S, Deters A, Schulz P, Rexin A, Vollmer S, Hauff P, Wiedenmann B, Pavel M, Scholz A. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.  Clin. Cancer Res.  2010;16;2  
•  van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.  Hepatology  2010;51;1  
•  Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, Hoosen S, St Peter J, Haas T, Lebwohl D, Van Cutsem E, Kulke MH, Hobday TJ, O'Dorisio TM, Shah MH, Cadiot G, Luppi G, Posey JA, Wiedenmann B. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.  J. Clin. Oncol.  2010;28;1  
•  Thelen A, Scholz A, Weichert W, Wiedenmann B, Neuhaus P, Geßner R, Benckert C, Jonas S. Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma.  Am. J. Gastroenterol.  2009  
•  Stecker K, Koschel A, Wiedenmann B, Anders M. Loss of Coxsackie and adenovirus receptor downregulates alpha-catenin expression.  Br. J. Cancer  2009;101;9  

[ See timeline ] [ See all publications ]